Sermonix Pharmaceuticals
PrivateLast Round
Strategic
Dec 18, 2023
Total Funding Raised
$107.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sermonix Pharmaceuticals is a biotechnology company that develops and commercializes female-specific oncology products, with a focus on treating ESR1-mutated metastatic breast and gynecological cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sermonix Pharmaceuticals Comparables
Compare Sermonix Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Olema Oncology | 80% | |
| Arvinas Inc | 80% | |
| Kind Pharmaceutical | 80% | |
Sermonix Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 18, 2023 | ||||
| Series A Extension | Nov 15, 2021 | ||||
| Series A | Jul 31, 2019 | ||||
| Seed | Oct 31, 2017 | ||||
| Seed | Nov 10, 2016 |
Sermonix Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perceptive Advisors | Series A Extension |
| Xontogeny | Series A Extension |
| WILD Family Office | Series A |
| HP WILD HOLDING AG | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
Global rights for certain assets acquired by Athira Pharma.
- Mar 25, 2025
Partnering with Regor Pharmaceuticals to advance breast cancer treatment.
Sermonix Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sermonix Pharmaceuticals's valuation, stock price, and market status.